Tourmaline Bio
7 known investors
Find your way into Tourmaline Bio
Sign up to see every warm intro you have to Tourmaline Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tourmaline Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Biotechnology company developing cellular therapies for organ transplantation and autoimmune disorders.
Investors · 7
Avoro Capital Advisorslisted by Avoro Capital AdvisorsNew York
How we know: Avoro Capital Advisors's portfolio page · Not right? Tell us
Longitude Capitallisted by Longitude CapitalMenlo Park · $10M – $30M
How we know: Longitude Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Scion Life Scienceslisted by Scion Life SciencesNew York · $1K – $60M
How we know: Scion Life Sciences's portfolio page · Not right? Tell us
Frequently asked questions
- What does Tourmaline Bio do?
- Biotechnology company developing cellular therapies for organ transplantation and autoimmune disorders.
- Who are Tourmaline Bio's investors?
- Tourmaline Bio's investors include Anjost, Avoro Capital Advisors, Longitude Capital, Scion Life Sciences, TCG Crossover, Vivo Capital, Qiming Venture Partners.



